PROCEPT BioRobotics Corp (PRCT) Stock Profile — Insider Trades & Financials

Revenue$76.4M

Net Income-$29.8M

EPS$-1.72

Gross Margin60.6%

Market Cap$1.3B

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Larry Wood

CEO & Executive Director

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Founded: 2009
Employees: 888
Headquarters: San Jose, California, United States

⚡

Core Efficiency

ROE?

-8.16%

ROA?

-5.87%

D/E Ratio?

0.39

Op. Margin?

-40.64%

📊

Profitability Ratios

Net Margin?

-39.07%

Loading company sections...

PROCEPT BioRobotics Corp

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness